Health Sector Headlines: International Drug Updates and Controversial Policies
Published on: Sept. 25, 2025, 2:27 a.m. | Source: Devdiscourse
The health sector is witnessing a range of significant developments, including Mexico's handling of a screwworm outbreak, J&J's product withdrawal, and legal sanctions against Sanofi. Trump's H-1B visa policy changes raise concerns about healthcare staffing, while gene therapy breakthroughs and failed trials impact the pharmaceutical industry.
